Antiaggregant therapy in neurological practice: objectives and possibilities
Based on the data available in the literature, the authors consider the prevention of ischemic stroke and other cardiovascular diseases in high-risk group patients. Timely identification and assessment of risk factors in a specific patient allow one to elaborate individual and the most optimal manag...
Main Authors: | E. V. Portnyagina, A. F. Portnyagin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2010-06-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/47 |
Similar Items
-
Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
by: Berger Peter B
Published: (2000-10-01) -
THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01) -
Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review
by: Salvatore Santo Signorelli, et al.
Published: (2020-08-01) -
PREVENTION OF ISCHEMIC STROKE Antiplatelet Agents, Carotid Endarterectomy and Angioplasty and Stenting
by: Harold P. Adams
Published: (2008-12-01) -
Short- and long-term outcomes of angioplasty and stenting for high-risk extracranial carotid stenosis in carotid endarterectomy
by: Kazemi-Saleh D, et al.
Published: (2012-06-01)